ENABLE - Online-based Digital Measurement of Patient Satisfaction, Health Related Quality of Life and Pateint Reported Outcaomes in Breast Cancer

ENABLE - Online-based Digital Measurement of Patient Satisfaction, Health Related Quality of Life and Pateint Reported Outcaomes in Breast Cancer - ENABLE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025611

Enrollment

600

Registered

2021-07-06

Start date

2021-03-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50.9

Interventions

Group 1: Systematic HRQoL measurement via digital queries under therapy. Additional weekly ePRO assessments and interventions based on reported adverse Events under therapy. Group 2: Systematic HRQoL

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Smartphoe with Access to the Internet. Invasive breast cancer bevor start of systemic therapy.

Exclusion criteria

Exclusion criteria: Very limited life expectancy, severe comorbidities that do not allow study participation. Psychological or cognitive inability for participation in a study.

Design outcomes

Primary

Measure	Time frame
Comparison of HRQoL and patients satisfaction under therapy between Intervention and control Group.	—

Secondary

Measure	Time frame
Feasibility of app-based queries in a neoadjuvant, adjuvant, post-neoadjuvant, follow-up and palliative Setting. Comparison of HRQoL between different therapies. Measurement of usability and acceptence of the application as a therapy companion.	—

Countries

Germany

Contacts

Public ContactCorinna Hartmann

Universitäts-Frauenklinik Heidelberg

enable@med.uni-heidelberg.de+4962215632505

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026